Erbitux cetuximab: Phase III data

By WIR Staff | Apr 16, 2007 | 7:00 AM GMT

First-line therapy with Erbitux plus gemcitabine failed to significantly improve overall survival vs. gemcitabine

Read the full 147 word article

How to gain access

Continue reading with a
two-week free trial.